Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ULTRALIFE CORP Director's Dealing 2022

Mar 4, 2022

34105_dirs_2022-03-04_be746890-2167-410b-81cf-b01d02010ef6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2022-03-02

Reporting Person: FAIN PHILIP A (CFO and Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-03-02 Common Stock; $.10 par value M 8500 $3.7103 Acquired 128500 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-03-02 Stock Options $3.7103 M 30000 Acquired 2022-03-03 Common Stock (30000) Direct

Footnotes

F1: (1) Represents shares of common stock acquired by the Reporting Person upon exercise of options for 30,000 shares of common stock of the Company, net of 21,500 shares of common stock, retained by the Company at a price determined pursuant to the terms of the Company's 2014 Long Term Incentive Plan, in payment of the exercise price for the options and the Reporting Person's individual minimum statutory withholding tax obligation.

F2: Represents exercise of options for 30,000 shares of common stock of the Company.